These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3892451)

  • 1. [Measles vaccination in the Sudan-Sahel region of Africa. Absence of the immunodepressive effect of malaria].
    Monjour L; Bourdillon F; Froment A; Daniel-Ribeiro C; Tirard S; Datry A; Chastang C; Tselentis Y; Gentilini M
    Pathol Biol (Paris); 1985 Apr; 33(4):232-5. PubMed ID: 3892451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rubella epidemiology in rural Upper Volta].
    Monjour L; Druilhe P; Huraux JM; Palminteri R; Froment A; Kyelem JM; Alfred C; Laplace JL; Gentilini M
    Acta Trop; 1982 Sep; 39(3):247-52. PubMed ID: 6128893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of measles vaccination in young malnourished African children].
    Monjour L; Bourdillon F; Froment A; Claudio-Ribeiro D; Fabre M; Chastang C; Gentilini M
    Bull Soc Pathol Exot Filiales; 1984; 77(3):271-7. PubMed ID: 6488419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles vaccination coverage during poliomyelitis national immunization days in Burkina Faso, 1999.
    Yaméogo KR; Yaméogo A; Nacoulma SD; Zuber PL
    J Infect Dis; 2003 May; 187 Suppl 1():S74-9. PubMed ID: 12721895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles incidence before and after mass vaccination campaigns in Burkina Faso.
    Kambiré C; Konde MK; Yaméogo A; Tiendrébéogo SR; Ouédraogo RT; Otten MW; Cairns KL; Zuber PL
    J Infect Dis; 2003 May; 187 Suppl 1():S80-5. PubMed ID: 12721896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migration as a risk factor for measles after a mass vaccination campaign, Burkina Faso, 2002.
    Yaméogo KR; Perry RT; Yaméogo A; Kambiré C; Kondé MK; Nshimirimana D; Kezaala R; Hersh BS; Cairns KL; Strebel P
    Int J Epidemiol; 2005 Jun; 34(3):556-64. PubMed ID: 15659463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of measles vaccination in Austria].
    Huber EG; Rannon L
    Padiatr Padol; 1973; 8(3):247-56. PubMed ID: 4715034
    [No Abstract]   [Full Text] [Related]  

  • 9. Mass measles vaccination in urban Burkina Faso, 1998.
    Zuber PL; Conombo KS; Traoré AD; Millogo JD; Ouattara A; Ouédraogo IB; Valian A
    Bull World Health Organ; 2001; 79(4):296-300. PubMed ID: 11357207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-measles vaccination and malaria].
    Richard-Lenoble D; Kombila M; Guillemot O; Guillemot F; Monjour L; Gendrel D
    Arch Fr Pediatr; 1987 Nov; 44(9):817-9. PubMed ID: 3328577
    [No Abstract]   [Full Text] [Related]  

  • 11. Measles outbreak in 31 schools: risk factors for vaccine failure and evaluation of a selective revaccination strategy.
    Yuan L
    CMAJ; 1994 Apr; 150(7):1093-8. PubMed ID: 8137189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles (rubeola) in previously immunized children.
    Baratta RO; Ginter MC; Price MA; Walker JW; Skinner RG; Prather EC; David JK
    Pediatrics; 1970 Sep; 46(3):397-402. PubMed ID: 4195394
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaccination of seropositive children against measles in Tanzania: boosting of antibody titres or a statistical artifact.
    Mandara MP; Remme J
    East Afr Med J; 1985 Jan; 62(1):12-20. PubMed ID: 4006810
    [No Abstract]   [Full Text] [Related]  

  • 14. [Measles vaccination of pre-school children: a detailed study of reaction frequency and side effects after immunization with vaccine of 3 different strengths].
    Böttiger M; Heller L; Kamensky P; Svanberg B
    Lakartidningen; 1974 Sep; 71(36):3270-4. PubMed ID: 4410083
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative studies of measles vaccines in a controlled trial in the USSR.
    Bolotovskij VM; Nefedova LA; Gelikman BG; Zargaryants AT; Zetilova LP; Nastasina KT
    Bull World Health Organ; 1966; 34(6):859-64. PubMed ID: 5296534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mass vaccination campaign against measles in Africa].
    Labusquiere R
    Med Trop (Mars); 1966; 26(5):483-96. PubMed ID: 6009275
    [No Abstract]   [Full Text] [Related]  

  • 17. [Description and survey of a measles epidemic in Burkina Faso].
    Schlumberger M; Sawadogo I; Sanou C; Traoré A; Rümke H; Roisin A
    Sante; 1995; 5(1):31-5. PubMed ID: 7894827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Simultaneous vaccination with BCG and measles vaccine: results of a controlled trial].
    Dutertre J; Labusquiere R; Boisson P; Gateff C; Barme P; Taylor M
    Rev Epidemiol Med Soc Sante Publique; 1975; 23(7-8):397-415. PubMed ID: 1084093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda.
    Mupere E; Karamagi C; Zirembuzi G; Grabowsky M; de Swart RL; Nanyunja M; Mayanja H
    Vaccine; 2006 May; 24(19):4111-5. PubMed ID: 16554111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical measles in children previously immunized with attenuated measles virus vaccines.
    Cherry JD; Feigin RD; Lobes LA; Shackelford PG
    Pediatrics; 1972 Nov; 50(5):712-7. PubMed ID: 5084185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.